Data gathered: September 17
Alternative Data for Nurix Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 75 | Sign up | Sign up | Sign up |
| Webpage traffic | 12,000 | Sign up | Sign up | Sign up |
| Google Trends | 31 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 550 | Sign up | Sign up | Sign up |
| Twitter Followers | 641 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 367 | Sign up | Sign up | Sign up |
About Nurix Therapeutics
Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.
| Price | $8.44 |
| Target Price | Sign up |
| Volume | 1,060,000 |
| Market Cap | $691M |
| Year Range | $8.44 - $20.15 |
| Dividend Yield | 0% |
| Analyst Rating | 93% buy |
| Industry | Biotechnology |
In the news
 |
Goldman Sachs Group Inc. Raises Stock Holdings in Nurix Therapeutics, Inc. $NRIXSeptember 16 - ETF Daily News |
 |
Nurix Therapeutics, Inc. (NRIX) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)September 11 - SeekingAlpha |
|
Nurix Therapeutics, Inc. (NRIX) Presents At Baird Global Healthcare Conference 2025 (Transcript)September 11 - SeekingAlpha |
|
Nurix Therapeutics, Inc. (NRIX) Presents At H.C. Wainwright 27th Annual Global Investment Conference TranscriptSeptember 10 - SeekingAlpha |
|
Nurix Therapeutics, Inc. (NRIX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 9 - SeekingAlpha |
|
Nurix Therapeutics, Inc. (NRIX) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 - SlideshowSeptember 5 - SeekingAlpha |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 44M | 0 | 44M | -43M | -48M | -0.520 |
| Q1 '25 | 18M | 4.1M | 18M | -56M | -59M | -0.670 |
| Q4 '24 | 13M | 4.3M | 13M | -59M | -60M | -0.750 |
| Q3 '24 | 13M | 4.1M | 4.1M | -49M | -50M | -0.670 |
| Q2 '24 | 12M | 4.1M | 8M | -45M | -44M | -0.710 |
Insider Transactions View All
| Van Houte Hans filed to sell 35,512 shares at $11. August 1 '25 |
| Hansen Gwenn filed to sell 69,023 shares at $12. July 30 '25 |
| Ring Christine filed to sell 44,009 shares at $12. July 30 '25 |
| Van Houte Hans filed to sell 40,914 shares at $12. July 30 '25 |
| Van Houte Hans filed to sell 33,724 shares at $11.3. May 2 '25 |
Similar companies
Read more about Nurix Therapeutics (NRIX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Nurix Therapeutics?
The Market Cap of Nurix Therapeutics is $691M.
What is the current stock price of Nurix Therapeutics?
Currently, the price of one share of Nurix Therapeutics stock is $8.44.
How can I analyze the NRIX stock price chart for investment decisions?
The NRIX stock price chart above provides a comprehensive visual representation of Nurix Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Nurix Therapeutics shares. Our platform offers an up-to-date NRIX stock price chart, along with technical data analysis and alternative data insights.
Does NRIX offer dividends to its shareholders?
As of our latest update, Nurix Therapeutics (NRIX) does not offer dividends to its shareholders. Investors interested in Nurix Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Nurix Therapeutics?
Some of the similar stocks of Nurix Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.